SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-003950
Filing Date
2024-01-08
Accepted
2024-01-08 08:13:56
Documents
7

Document Format Files

Seq Description Document Type Size
1 DEFA14A d110586ddefa14a.htm DEFA14A 47293
2 EX-2.1 d110586dex21.htm EX-2.1 460358
3 EX-99.1 d110586dex991.htm EX-99.1 17866
4 EX-99.2 d110586dex992.htm EX-99.2 17715
5 EX-99.3 d110586dex993.htm EX-99.3 37042
6 EX-99.4 d110586dex994.htm EX-99.4 989
7 EX-99.5 d110586dex995.htm EX-99.5 13881
  Complete submission text file 0001193125-24-003950.txt   596274
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma, Inc. (Filer) CIK: 0001990550 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-56600 | Film No.: 24518456
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)